PCI BIOTECH HOLDING ASA: årsregnskap 2025 vs 2024
Weaker earnings, cash halved-plus
approved 2026-06-30; registry 2026-07-30; journal 2026 623409
Summary
What changed
Comparing Årsregnskap 2025 with 2024 for PCI BIOTECH HOLDING ASA. Revenue 0 NOK → 2.94m NOK. Net result -35.3k NOK → -42.29m NOK. Equity 43.99m NOK → 2.90m NOK.
On the constructive side: revenue rose; operating result improved. Pressures included: net result weakened; equity eroded; cash fell.
Also worth watching: paid-in equity reduced; book investments changed. All figures are taken from the published annual accounts for PCI BIOTECH HOLDING ASA.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 0 NOK to 2.94m NOK. Calculated
-
↑
Operating result improved
Operating result -4.23m NOK → -3.97m NOK. Calculated
What deteriorated
-
↓
Net result weakened
Net result -35.3k NOK → -42.29m NOK. Calculated
-
↓
Equity eroded
Book equity 43.99m NOK → 2.90m NOK (equity ratio 95.8% → 33.7%). Calculated
-
↓
Cash fell
Bank deposits 540.0k NOK → 154.0k NOK (-71.5% YoY). Calculated
-
↓
Current ratio dropped below 1×
Current ratio 34186.95× → 0.11× — short-term liabilities now exceed liquid/current assets on the published lines. Calculated
Things to notice
-
·
Paid-in equity reduced
Paid-in equity fell 43.99m NOK → 2.90m NOK — check capital reduction, conversion, or reclassification. Interpretation
-
·
Book investments changed
Investment / intangible book value 45.28m NOK → 0 NOK. Reported fact